Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This article addresses the definition, diagnosis, and characteristics of telogen effluvium, a form of diffuse hair loss, but reports no new clinical results.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

This review discusses the association between emotional stress-related neuropeptides and the pathogenesis of alopecia areata, reporting no new experimental findings.

This study found that acute telogen effluvium after COVID-19 typically began about 1.5 months post-infection and resolved sooner than typical cases, with most resolving in under two months.

This case series reports telogen effluvium in three patients following severe Sars-Cov-2 infection and suggests a potential association that merits further investigation.

This review suggests that the Mediterranean diet, protein-rich diets, and soy may support hair health in nonscarring alopecias like androgenetic alopecia.

This study reports a case of a 17-year-old girl experiencing telogen effluvium after COVID-19, with hair loss starting two to twelve weeks post-illness.

This case study describes hair loss as a potential late complication of multisystem inflammatory syndrome in children, observed in a 7-year-old girl who developed Telogen effluvium 73 days post-diagnosis.

This review discusses telogen effluvium as a common cause of diffuse hair loss and reports no new clinical results, noting diagnostic and treatment challenges.

This study found that patients with SARS-CoV-2 associated telogen effluvium experienced hair loss sooner after infection compared to telogen effluvium from other causes, with distinct dermoscopic findings aiding diagnosis.

Vitamin D deficiency is common in temporary hair loss, and stress is often a suspected cause.

This article describes acute and chronic telogen effluvium, highlighting the importance of differentiating them from androgenetic alopecia for accurate diagnosis and treatment strategies but includes no new clinical research findings.

This chapter reviews common drug-related and systemic disorder-induced alopecias, focusing on their epidemiology, causes, symptoms, diagnosis, and treatment, but reports no new findings.

This article discusses telogen effluvium, emphasizing the importance of understanding its natural progression and highlights the need for a detailed patient evaluation but provides no new clinical results.

This article discusses the clinical features and treatment options for common types of hair loss in women and reports no new clinical results.

This review discusses age-related and environmental factors affecting scalp hair changes in women, highlighting diagnostic complexities and ongoing research into targeted treatments, without reporting new clinical results.

In this study, serum zinc levels in telogen effluvium patients showed no significant difference compared to healthy controls.

This review examines the complex relationship between hair loss, particularly in alopecia areata, and psychological/psychiatric conditions, concluding that stress and emotional factors frequently contribute to hair loss or alter treatment choices; it reports no new results.

This article is a case report on severe hair loss due to telogen effluvium occurring during inpatient rehabilitation and does not provide new clinical results.

This review discusses the causes and treatments of hair loss in women, such as telogen effluvium and female pattern hair loss, and provides no new research results.

This article reviews various factors contributing to telogen effluvium and examines potential treatments like Minoxidil, but reports no new clinical findings.

The abstract notes that while telogen effluvium—a condition causing diffuse hair loss—is triggered by stressors like significant weight loss, there is limited literature specifically exploring the connection between telogen effluvium and weight loss.

This review discusses the complex diagnosis and management of telogen effluvium, noting its high prevalence, psychosocial impact, and need for quantitative diagnostic techniques, but it reports no new research findings.

This article describes telogen effluvium as diffuse cyclic hair loss in women caused by systemic stresses, diseases, or physiological situations, but reports no new clinical results.

This article discusses telogen effluvium as a common type of temporary hair loss due to stress, but it does not report new findings; the authors highlight ongoing hair growth.

This review discusses evidence-based complementary strategies for enhancing hair regrowth after post-COVID-19 telogen effluvium and reports no new clinical results.

This article reviews current knowledge about diffuse telogen effluvium, focusing on its classification, clinical features, causes, and diagnostic and treatment approaches.

This review discusses the five functional subtypes of telogen effluvium proposed by Headington and reports no new experimental findings.

This review explores the potential connection between GA and various types of alopecia but reports no new clinical findings, emphasizing the need for further research.

This case report highlights the importance of considering telogen effluvium in young men with hair loss resembling male androgenetic alopecia to prevent misdiagnosis and unnecessary treatment.